P Lurie

Summary

Affiliation: Public Citizen's Health Research Group
Country: USA

Publications

  1. pmc Selected science: an industry campaign to undermine an OSHA hexavalent chromium standard
    David Michaels
    Project on Scientific Knowledge and Public Policy, Department of Environmental and Occupational Health, The George Washington University School of Public Health and Health Services, Washington, DC 20037, USA
    Environ Health 5:5. 2006
  2. ncbi request reprint Continuing exposure to hexavalent chromium, a known lung carcinogen: an analysis of OSHA compliance inspections, 1990-2000
    Peter Lurie
    Public Citizen s Health Research Group, Washington, DC 20009, USA
    Am J Ind Med 42:378-83. 2002
  3. ncbi request reprint US exceptionalism comes to research ethics
    Peter Lurie
    Public Citizen s Health Research Group, Washington, DC 20009, USA
    Lancet 365:1117-9. 2005
  4. ncbi request reprint Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings
    Peter Lurie
    Public Citizen s Health Research Group, Washington, DC 20009, USA
    JAMA 295:1921-8. 2006
  5. doi request reprint Case series of liver failure associated with rosiglitazone and pioglitazone
    James S Floyd
    Public Citizen, Health Research Group, 1600 20th Street NW, Washington, DC 20009, USA
    Pharmacoepidemiol Drug Saf 18:1238-43. 2009
  6. ncbi request reprint Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting
    Peter Lurie
    Public Citizen s Health Research Group, 1600 20th Street, NW, Washington, DC 20009, USA
    J Public Health Policy 26:389-99. 2005
  7. doi request reprint DTC advertising harms patients and should be tightly regulated
    Peter Lurie
    Health Research Group, Public Citizen, Washington, D C, USA
    J Law Med Ethics 37:444-50, 396. 2009
  8. ncbi request reprint Hexavalent chromium study's conclusions unjustified
    Altoon Dweck
    J Occup Environ Med 47:980-1; author reply 981. 2005
  9. ncbi request reprint Lung cancer mortality in the German chromate industry, 1958 to 1998
    David Michaels
    J Occup Environ Med 48:995-7; author reply 997-8. 2006
  10. pmc Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings
    Peter Lurie
    MedGenMed 8:22. 2006

Collaborators

Detail Information

Publications16

  1. pmc Selected science: an industry campaign to undermine an OSHA hexavalent chromium standard
    David Michaels
    Project on Scientific Knowledge and Public Policy, Department of Environmental and Occupational Health, The George Washington University School of Public Health and Health Services, Washington, DC 20037, USA
    Environ Health 5:5. 2006
    ....
  2. ncbi request reprint Continuing exposure to hexavalent chromium, a known lung carcinogen: an analysis of OSHA compliance inspections, 1990-2000
    Peter Lurie
    Public Citizen s Health Research Group, Washington, DC 20009, USA
    Am J Ind Med 42:378-83. 2002
    ..In 1993, Public Citizen and the Paper, Allied-Industrial, Chemical and Energy Workers International Union (PACE) petitioned to lower the PEL from the current 100 microg/m(3) to 0.5 microg/m(3) as an 8-hr time-weighted average (TWA)...
  3. ncbi request reprint US exceptionalism comes to research ethics
    Peter Lurie
    Public Citizen s Health Research Group, Washington, DC 20009, USA
    Lancet 365:1117-9. 2005
  4. ncbi request reprint Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings
    Peter Lurie
    Public Citizen s Health Research Group, Washington, DC 20009, USA
    JAMA 295:1921-8. 2006
    ..In January 2002, the US Food and Drug Administration (FDA) issued a draft guidance requiring more detailed financial conflict of interest disclosure at advisory committee meetings...
  5. doi request reprint Case series of liver failure associated with rosiglitazone and pioglitazone
    James S Floyd
    Public Citizen, Health Research Group, 1600 20th Street NW, Washington, DC 20009, USA
    Pharmacoepidemiol Drug Saf 18:1238-43. 2009
    ..We evaluated the FDA Adverse Event Reporting System (AERS) to determine the number of reported cases of liver failure associated with rosiglitazone and pioglitazone between 1997 and 2006, and described their clinical characteristics...
  6. ncbi request reprint Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting
    Peter Lurie
    Public Citizen s Health Research Group, 1600 20th Street, NW, Washington, DC 20009, USA
    J Public Health Policy 26:389-99. 2005
    ..Over half of all companies (54%) were in violation of either APA rules or FDA regulations. The APA's voluntary code has failed to adequately reduce inappropriate promotional activity at the annual APA meeting...
  7. doi request reprint DTC advertising harms patients and should be tightly regulated
    Peter Lurie
    Health Research Group, Public Citizen, Washington, D C, USA
    J Law Med Ethics 37:444-50, 396. 2009
    ..The objective, of course, is to realize any unique benefits while minimizing the risks. On balance, the adverse effects of DTC advertising outweigh the still-undemonstrated benefits of the advertising...
  8. ncbi request reprint Hexavalent chromium study's conclusions unjustified
    Altoon Dweck
    J Occup Environ Med 47:980-1; author reply 981. 2005
  9. ncbi request reprint Lung cancer mortality in the German chromate industry, 1958 to 1998
    David Michaels
    J Occup Environ Med 48:995-7; author reply 997-8. 2006
  10. pmc Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings
    Peter Lurie
    MedGenMed 8:22. 2006
  11. doi request reprint Updated estimates of pharmaceutical company payments to physicians in Vermont
    Joseph S Ross
    JAMA 300:1998-2000. 2008
  12. ncbi request reprint Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota
    Joseph S Ross
    Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, NY 10029, USA
    JAMA 297:1216-23. 2007
    ..Recent legislation in 5 states and the District of Columbia mandated state disclosure of payments made to physicians by pharmaceutical companies. In 2 of these states, Vermont and Minnesota, payment disclosures are publicly available...
  13. ncbi request reprint Suboptimum use of FDA drug advisory committees
    Asa L Tapley
    Lancet 368:2210. 2006
  14. ncbi request reprint U.S. physicians disciplined for criminal activity
    Paul Jung
    University of Maryland, College Park, USA
    Health Matrix Clevel 16:335-50. 2006
  15. ncbi request reprint Responding to three articles regarding vagus nerve stimulation (VNS) for depression
    Peter Lurie
    Biol Psychiatry 60:1382; author reply 1382-3. 2006
  16. ncbi request reprint The pharmaceutical industry and disease mongering. Déjà vu all over again
    Matthew Anderson
    BMJ 325:216; author reply 216. 2002